The global predictive genetic testing and consumer genomics market is expected to soar through 2025, according to a Research and Markets report. Here are four things to know about the market. It’s ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

A new study published in the US medical journal ‘The Annals of Internal Medicine’ makes a very strong case for universal genetic testing at the age of 30. This would detect and, if necessary, start ...

New University of Utah research reveals the potential of medication informatics and DNA drug-sensitivity testing to reduce overall healthcare resource use and costs in elderly patients treated with ...

Over 20% of high-grade serous ovarian cancer patients have BRCA mutations, and up to 50% exhibit HRD, impacting DNA repair pathways. Global guidelines recommend BRCA and HRD testing, but many eligible ...

Abbott’s major takeover of Exact Sciences showcases a rising push to leverage cancer tests in precision oncology therapy and R&D.

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global population to develop overweight or obesity by 2035. However, treatment ...

Here, we review key updates in genetic and genomic testing for prostate cancer, including clinical implications of testing for advanced disease, the role of RNA expression tests with emphasis on ...

Doctors will be able to tap on AI for early interventions against chronic diseases; while subsidised genetic testing will be available for hereditary breast and ovarian cancer, and enhancements will ...